ValueSet-2.16.840.1.113883.3.3157.1023

Sourceus.nlm.vsac#0.11.0:null (v4.0.1)
resourceTypeValueSet
id2.16.840.1.113883.3.3157.1023
canonicalhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1023
version20200716
statusactive
publisherLewin EH Steward
nameLiverLesionMassOrNeoplasm
titleLiver Lesion (Mass or Neoplasm)
date2020-07-16T01:00:25-04:00
experimentalfalse
descriptionThis value set is used to calculate OP-10 (Abdomen Computed Tomography (CT)—Use of Contrast Material), a claims-based measure used in the Centers for Medicare & Medicaid Services' Hospital Outpatient Quality Reporting (HOQR) Program. In calculation of OP-10, diagnoses of liver lesion (mass or neoplasm) must appear on the abdomen CT claim to be excluded from the measure’s initial patient population.
Usages(none)

This value set contains 14 concepts

Code System Display
   C22.0 http://hl7.org/fhir/sid/icd-10-cm Liver cell carcinoma
   C22.1 http://hl7.org/fhir/sid/icd-10-cm Intrahepatic bile duct carcinoma
   C22.2 http://hl7.org/fhir/sid/icd-10-cm Hepatoblastoma
   C22.3 http://hl7.org/fhir/sid/icd-10-cm Angiosarcoma of liver
   C22.4 http://hl7.org/fhir/sid/icd-10-cm Other sarcomas of liver
   C22.7 http://hl7.org/fhir/sid/icd-10-cm Other specified carcinomas of liver
   C22.8 http://hl7.org/fhir/sid/icd-10-cm Malignant neoplasm of liver, primary, unspecified as to type
   C22.9 http://hl7.org/fhir/sid/icd-10-cm Malignant neoplasm of liver, not specified as primary or secondary
   C78.7 http://hl7.org/fhir/sid/icd-10-cm Secondary malignant neoplasm of liver and intrahepatic bile duct
   C7B.02 http://hl7.org/fhir/sid/icd-10-cm Secondary carcinoid tumors of liver
   D01.5 http://hl7.org/fhir/sid/icd-10-cm Carcinoma in situ of liver, gallbladder and bile ducts
   D13.4 http://hl7.org/fhir/sid/icd-10-cm Benign neoplasm of liver
   D13.5 http://hl7.org/fhir/sid/icd-10-cm Benign neoplasm of extrahepatic bile ducts
   D37.6 http://hl7.org/fhir/sid/icd-10-cm Neoplasm of uncertain behavior of liver, gallbladder and bile ducts

Produced 08 Sep 2023